लोड हो रहा है...
Immunotherapy in Head and Neck Squamous Cell Cancer
Prognosis in relapsed metastatic head and neck squamous cell cancer (RM-HNSCC) is dismal. Platinum based chemotherapy in combination with Cetuximab is used in first-line setting, while no further validated options are available at progression. Immunotherapy has produced durable clinical benefit in s...
में बचाया:
| में प्रकाशित: | Clin Exp Otorhinolaryngol |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Korean Society of Otorhinolaryngology-Head and Neck Surgery
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6222190/ https://ncbi.nlm.nih.gov/pubmed/29973040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21053/ceo.2018.00150 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|